A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

Glucagon in turn releases glucose stores when we need a supply of energy. These two cell-types also communicate directly with each other to optimize the correct glucose level in the body.

Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...

A few years later this factor was identified as glucagon. Since these pivotal discoveries, we now know that islets comprise the endocrine portion of the pancreas. Within islets, beta cells secrete ...

At the heart of this discovery lies the role of glucagon-like peptide-1 (GLP-1), a hormone known ... The study also sheds light on the specific cells involved. GLP-1 receptors were found to be ...

Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With the potential to significantly change consumer eating habits, they are ...

Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) are secreted from the same intestinal cells following meal ingestion. GLP-1 is now widely recognised to reduce blood glucose levels ...

stimulates liver cells to take up glucose from the blood and Glucagon: released from pancreas, stimulates liver cells to release glucose into the blood Antibodies Part of the immune system.